$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Current evidence on the use of probiotics in liver diseases

Journal of functional foods : the official journal of the International Society for Nutraceuticals & Functional Foods, v.17, 2015년, pp.137 - 151  

Chavez-Tapia, N.C. ,  Gonzalez-Rodriguez, L. ,  Jeong, M. ,  Lopez-Ramirez, Y. ,  Barbero-Becerra, V. ,  Juarez-Hernandez, E. ,  Romero-Flores, J.L. ,  Arrese, M. ,  Mendez-Sanchez, N. ,  Uribe, M.

Abstract AI-Helper 아이콘AI-Helper

The human gastrointestinal tract contains bacterial species that, among other functions, maintain a microbial barrier against potential pathogens and help regulate the immune response in the human body. The composition of gut microbiota and its variations hold an important role in the development of...

주제어

참고문헌 (105)

  1. Nature Aderem 406 6797 782 2000 10.1038/35021228 Toll-like receptors in the induction of the innate immune response 

  2. P & T Alaniz 34 4 204 2009 Spontaneous bacterial peritonitis: A review of treatment options 

  3. European Review for Medical and Pharmacological Sciences Aller 15 9 1090 2011 Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: A double blind randomized clinical trial 

  4. Nutrition Reviews Backhed 70 Suppl. 1 S14 2012 10.1111/j.1753-4887.2012.00496.x Host responses to the human microbiome 

  5. Proceedings of the National Academy of Sciences of the United States of America Backhed 101 44 15718 2004 10.1073/pnas.0407076101 The gut microbiota as an environmental factor that regulates fat storage 

  6. Expert Review of Gastroenterology & Hepatology Bajaj 2 6 785 2008 10.1586/17474124.2.6.785 Management options for minimal hepatic encephalopathy 

  7. Alimentary Pharmacology and Therapeutics Bajaj 39 10 1113 2014 10.1111/apt.12695 Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis 

  8. Trends in Microbiology Berg 4 11 430 1996 10.1016/0966-842X(96)10057-3 The indigenous gastrointestinal microflora 

  9. Journal of Hepatology Bogdanos 40 1 31 2004 10.1016/S0168-8278(03)00501-4 Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis 

  10. Hepatology (Baltimore, Md.) Bogdanos 42 2 458 2005 10.1002/hep.20788 Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic 

  11. PLoS ONE Borthakur 8 10 e75664 2013 10.1371/journal.pone.0075664 Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells 

  12. American Journal of Physiology. Gastrointestinal and Liver Physiology Caballero-Franco 292 1 G315 2007 10.1152/ajpgi.00265.2006 The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells 

  13. The Lancet Infectious Diseases Cainelli 2 9 539 2002 10.1016/S1473-3099(02)00370-5 Infections and solid organ transplant rejection: A cause-and-effect relationship? 

  14. Annual Review of Physiology Carvalho 74 177 2012 10.1146/annurev-physiol-020911-153330 Toll-like receptor-gut microbiota interactions: Perturb at your own risk! 

  15. Digestive and Liver Disease Cesaro 43 6 431 2011 10.1016/j.dld.2010.10.015 Gut microbiota and probiotics in chronic liver diseases 

  16. BMC Gastroenterology Chang 13 151 2013 10.1186/1471-230X-13-151 The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury 

  17. Molecular Medicine Reports Chen 7 2 401 2013 10.3892/mmr.2012.1188 Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis 

  18. Nutrition (Burbank, Los Angeles County, Calif.) Cunningham-Rundles 14 7-8 573 1998 10.1016/S0899-9007(98)00029-X Nutrition and the immune system of the gut 

  19. American Journal of Surgery Eguchi 201 4 498 2011 10.1016/j.amjsurg.2010.02.013 Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: A prospective randomized study 

  20. The American Journal of Clinical Nutrition El-Nezami 83 5 1199 2006 10.1093/ajcn/83.5.1199 Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China 

  21. PLoS ONE Endo 8 5 e63388 2013 10.1371/journal.pone.0063388 Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: New insight into the probiotics for the gut-liver axis 

  22. MBio Everard 5 3 e1011 2014 10.1128/mBio.01011-14 Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice 

  23. Food and Agriculture Organization of the United Nations and World Health Organization 2002 Guidelines for the evaluation of probiotics in food 

  24. Hepatology (Baltimore, Md.) Garcia-Tsao 51 4 1445 2010 10.1002/hep.23478 Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis 

  25. Best Practice and Research. Clinical Gastroenterology Garcia-Tsao 18 2 353 2004 10.1016/j.bpg.2003.10.005 Gut microflora in the pathogenesis of the complications of cirrhosis 

  26. Liver International Gupta 33 8 1148 2013 10.1111/liv.12172 Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: A randomized trial 

  27. Microbes and Infection Haller 9 14-15 1636 2007 10.1016/j.micinf.2007.09.010 The Mx GTPase family of interferon-induced antiviral proteins 

  28. PLoS ONE Hayashi 8 7 e70034 2013 10.1371/journal.pone.0070034 Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease 

  29. World Journal of Gastroenterology Hegazy 16 33 4145 2010 10.3748/wjg.v16.i33.4145 Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis 

  30. Journal of Autoimmunity Henao-Mejia 46 66 2013 10.1016/j.jaut.2013.07.001 Role of the intestinal microbiome in liver disease 

  31. Nature Reviews. Gastroenterology & Hepatology Hill 11 8 506 2014 10.1038/nrgastro.2014.66 Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic 

  32. Journal of Hepatology Honda 47 3 404 2007 10.1016/j.jhep.2007.03.012 Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis 

  33. PLoS ONE Hong 10 2 e0117451 2015 10.1371/journal.pone.0117451 Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease 

  34. Lancet Hopf 2 8677 1419 1989 10.1016/S0140-6736(89)92034-5 Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis 

  35. Hepatology (Baltimore, Md.) Hosel 55 1 287 2012 10.1002/hep.24625 Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors 

  36. Hepatitis Monthly Imani Fooladi 13 2 e7521 2013 10.5812/hepatmon.7521 Probiotic as a novel treatment strategy against liver disease 

  37. Journal of Functional Foods Juarez 5 4 1761 2013 10.1016/j.jff.2013.08.002 Lactobacillus reuteri CRL1101 beneficially modulate lipopolysaccharide-mediated inflammatory response in a mouse model of endotoxic shock 

  38. Gastroenterology Karrar 132 4 1504 2007 10.1053/j.gastro.2007.01.039 Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis 

  39. Gene Kumar 490 1-2 54 2011 10.1016/j.gene.2011.09.003 Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB(1)-induced hepatocellular carcinoma 

  40. Pediatrics Land 115 1 178 2005 10.1542/peds.2004-2137 Lactobacillus sepsis associated with probiotic therapy 

  41. World Journal of Gastroenterology Lata 17 24 2890 2011 10.3748/wjg.v17.i24.2890 Probiotics in hepatology 

  42. Nature Reviews. Immunology Latz 13 6 397 2013 10.1038/nri3452 Activation and regulation of the inflammasomes 

  43. Archives of Pharmacal Research Lee 36 12 1525 2013 10.1007/s12272-013-0141-3 Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus 

  44. The New England Journal of Medicine Lee 332 14 924 1995 10.1056/NEJM199504063321406 Primary sclerosing cholangitis 

  45. Seminars in Liver Disease Levy 26 1 22 2006 10.1055/s-2006-933560 Primary sclerosing cholangitis: Epidemiology, natural history, and prognosis 

  46. Journal of Functional Foods Li 8 May 340 2014 10.1016/j.jff.2014.03.031 Cholesterol-lowering effect of Lactobacillus plantarum NCU116 in a hyperlipidaemic rat model 

  47. World Journal of Gastroenterology Li 18 16 1975 2012 10.3748/wjg.v18.i16.1975 Analysis of infections in the first 3-month after living donor liver transplantation 

  48. The American Journal of Gastroenterology Loguercio 97 8 2144 2002 10.1111/j.1572-0241.2002.05942.x Gut-liver axis: A new point of attack to treat chronic liver damage? 

  49. Journal of Clinical Gastroenterology Loguercio 39 6 540 2005 10.1097/01.mcg.0000165671.25272.0f Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 

  50. Zhonghua Gan Zang Bing Za Zhi Lu 16 4 283 2008 [Changes of plasma cytokines in patients with severe hepatitis treated with a probiotic preparation] 

  51. World Journal of Gastroenterology: WJG Ma 19 40 6911 2013 10.3748/wjg.v19.i40.6911 Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis 

  52. Science Macpherson 303 5664 1662 2004 10.1126/science.1091334 Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria 

  53. Expert Review of Gastroenterology & Hepatology Mandair 8 4 369 2014 10.1586/17474124.2014.894879 The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma 

  54. Hepatology (Baltimore, Md.) Mao 42 4 802 2005 10.1002/hep.20859 Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis 

  55. Frontiers in Physiology Massey 3 193 2012 10.3389/fphys.2012.00193 Acute alcohol-induced liver injury 

  56. BMJ Open McFarland 4 8 e005047 2014 10.1136/bmjopen-2014-005047 Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: A systematic review 

  57. Clinical Nutrition (Edinburgh, Scotland) McNaught 24 2 211 2005 10.1016/j.clnu.2004.08.008 A prospective randomised trial of probiotics in critically ill patients 

  58. Current Pharmaceutical Design Mercenier 9 2 175 2003 10.2174/1381612033392224 Probiotics as biotherapeutic agents: Present knowledge and future prospects 

  59. Journal of Functional Foods Miremadi 9 295 2014 10.1016/j.jff.2014.05.002 Cholesterol reduction mechanisms and fatty acid composition of cellular membranes of probiotic Lactobacilli and Bifidobacteria 

  60. European Journal of Nutrition Moratalla 2015 Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis 

  61. Liver International Mueller 31 10 1574 2011 10.1111/j.1478-3231.2011.02635.x Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis 

  62. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America Munoz 40 11 1625 2005 10.1086/429916 Saccharomyces cerevisiae fungemia: An emerging infectious disease 

  63. The Journal of Pediatrics Murguia-Peniche 162 3 Suppl. S64 2013 10.1016/j.jpeds.2012.11.055 Intestinal mucosal defense system, Part 2. Probiotics and prebiotics 

  64. Anales de Pediatria Narbona Lopez 81 6 397 2014 [Nutrition and Metabolism Group of the Spanish Neonatology Society: Recommendations and evidence for dietary supplementation with probiotics in very low birth weight infants] 

  65. American Journal of Physiology. Gastrointestinal and Liver Physiology Nardone 299 3 G669 2010 10.1152/ajpgi.00188.2010 Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury 

  66. Gastroenterology Neish 136 1 65 2009 10.1053/j.gastro.2008.10.080 Microbes in gastrointestinal health and disease 

  67. Interdisciplinary Perspectives on Infectious Diseases O'Toole 2008 175285 2008 10.1155/2008/175285 Probiotic bacteria influence the composition and function of the intestinal microbiota 

  68. European Journal of Gastroenterology and Hepatology Pande 24 7 831 2012 10.1097/MEG.0b013e3283537d61 Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: A double-blind placebo-controlled randomized-controlled trial 

  69. Inflammatory Bowel Diseases Pastor Rojo 13 3 269 2007 10.1002/ibd.20019 Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease 

  70. International Journal of Research in Pharmaceutical and Biomedical Sciences Pawar 3 1 206 2014 Study of effects of probiotic Lactobacilli in preventing major complications in patients of liver cirrhosis 

  71. Nutrition (Burbank, Los Angeles County, Calif.) Pereg 27 2 177 2011 10.1016/j.nut.2010.01.006 Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study 

  72. Pietro 363 2014 Nutrition in the prevention and treatment of abdominal obesity Probiotics to treat visceral obesity and related liver disease 

  73. Alcohol (Fayetteville, N.Y.) Purohit 42 5 349 2008 10.1016/j.alcohol.2008.03.131 Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: Summary of a symposium 

  74. Journal of Functional Foods Qiao 14 424 2015 10.1016/j.jff.2015.02.013 Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat-diet-induced obesity mice model 

  75. Transplantation Rayes 74 1 123 2002 10.1097/00007890-200207150-00021 Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients 

  76. American Journal of Transplantation Rayes 5 1 125 2005 10.1111/j.1600-6143.2004.00649.x Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - A randomized, double-blind trial 

  77. Hepatobiliary and Pancreatic Diseases International Ren 10 5 489 2011 10.1016/S1499-3872(11)60083-0 Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation 

  78. Seminars in Immunology Robertson 24 1 9 2012 10.1016/j.smim.2012.01.001 Examining host-microbial interactions through the lens of NOD: From plants to mammals 

  79. Obesity Surgery Ruiz 17 10 1374 2007 10.1007/s11695-007-9243-7 Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: Evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis 

  80. Journal of Functional Foods Senaka Ranadheera 8 18 2014 10.1016/j.jff.2014.02.022 Effect of diary probiotic combinations on in vitro gastrointestinal tolerance, intestinal epithelial cell adhesion and cytokine secretion 

  81. The Permanente Journal Sharma 17 4 62 2013 10.7812/TPP/12-144 Probiotics and liver disease 

  82. Hepatology (Baltimore, Md.) Shimoda 53 4 1270 2011 10.1002/hep.24194 Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis 

  83. Vaccine Soh 28 14 2577 2010 10.1016/j.vaccine.2010.01.020 Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination 

  84. Journal of Hepatology Stadlbauer 48 6 945 2008 10.1016/j.jhep.2008.02.015 Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis 

  85. Clinical Immunology Sugimura 149 3 509 2013 10.1016/j.clim.2013.10.007 Immunomodulatory effect of Lactococcus lactis JCM5805 on human plasmacytoid dendritic cells 

  86. International Journal of Hepatology Sung 2012 439024 2012 10.1155/2012/439024 Regulation of T helper 17 by bacteria: An approach for the treatment of hepatocellular carcinoma 

  87. Liver International Tandon 29 7 1110 2009 10.1111/j.1478-3231.2009.02020.x Effects of probiotic therapy on portal pressure in patients with cirrhosis: A pilot study 

  88. Environmental Microbiology Tap 11 10 2574 2009 10.1111/j.1462-2920.2009.01982.x Towards the human intestinal microbiota phylogenetic core 

  89. The Journal of Nutrition Thuy 138 8 1452 2008 10.1093/jn/138.8.1452 Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake 

  90. Nature Turnbaugh 444 7122 1027 2006 10.1038/nature05414 An obesity-associated gut microbiome with increased capacity for energy harvest 

  91. JPEN. Journal of Parenteral and Enteral Nutrition Usami 35 3 317 2011 10.1177/0148607110379813 Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis 

  92. Journal of Pediatric Gastroenterology and Nutrition Vajro 52 6 740 2011 10.1097/MPG.0b013e31821f9b85 Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease 

  93. Transplant Infectious Disease Vera 13 6 608 2011 10.1111/j.1399-3062.2011.00640.x Incidence and risk factors for infections after liver transplant: Single-center experience at the University Hospital Fundacion Santa Fe de Bogota, Colombia 

  94. Hepatology (Baltimore, Md.) Visvanathan 45 1 102 2007 10.1002/hep.21482 Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein 

  95. European Journal of Gastroenterology and Hepatology Vleggaar 20 7 688 2008 10.1097/MEG.0b013e3282f5197e Probiotics in primary sclerosing cholangitis: A randomized placebo-controlled crossover pilot study 

  96. Journal of Autoimmunity Wang 25 1 85 2005 10.1016/j.jaut.2005.05.003 Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis 

  97. Journal of Hepatology Wang 51 6 1037 2009 10.1016/j.jhep.2009.06.020 Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication 

  98. Cytokine Weiss 56 2 520 2011 10.1016/j.cyto.2011.07.024 Lactobacilli and bifidobacteria induce differential interferon-beta profiles in dendritic cells 

  99. American Journal of Health-System Pharmacy Williams 67 6 449 2010 10.2146/ajhp090168 Probiotics 

  100. Gut Xu 51 1 120 2002 10.1136/gut.51.1.120 High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6 

  101. Microbial Ecology Xu 63 2 304 2012 10.1007/s00248-011-9925-5 Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease 

  102. Journal of Clinical Biochemistry and Nutrition Xu 50 1 72 2012 10.3164/jcbn.11-38 Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model 

  103. Liver International Yokoyama 26 4 467 2006 10.1111/j.1478-3231.2006.01254.x Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways 

  104. The Journal of Nutritional Biochemistry Zhang 2014 Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease 

  105. European Journal of Gastroenterology and Hepatology Zhang 22 12 1481 2010 Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로